NaturesPlus Glucosamine Joint Cream Recall for Microbial Contamination
NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx Joint Cream is being recalled due to microbial contamination identified as Pluralibacter gergoviae in a non-sterile product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for microbial contamination of a non-sterile product. The source text does not report any illnesses or injuries, making this a precautionary recall based on a theoretical contamination hazard rather than documented harm.
Plain-English summary
Organics Corporation of America, doing business as Ambix Laboratories, is recalling NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx Joint Cream, 4 oz tubes, due to microbial contamination. The contaminating agent identified is Pluralibacter gergoviae, found in the non-sterile product.
A total of 4,214 tubes with product code 4929 and lot number 23622 are affected by this recall. The product was distributed to one consignee: Natural Organics, Inc., located at 548 Broadhollow Road, Melville, NY 11747.
Consumers who have purchased this product should stop using it and contact their healthcare provider or pharmacist if they have any concerns about exposure or adverse effects.
The recalled product
- Product
- NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, Manufactured for NaturesPlus 548 Broadhollow Road, Melville, NY 11747, USA
- Manufacturer
- Organics Corporation of America DBA Ambix Laboratories
- Hazard
- microbial-contamination
- pluralibacter-gergoviae
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Product code 4929
- Lot # 23622
Distribution
Distributed in 1 state:
- NY
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27